Table 4

Regression model estimating the influence of patient characteristics on (A) changes in health utilisation after switch, and (B) changes in costs after switch. Models include interaction term ‘after’ and adjusting variables†

Interaction term
After*gender (Male=1)After*age/yearAfter*ETA duration‡
Exp (estimate)P valueExp (estimate)P valueExp (estimate)P value
(A) Changes in health utilisation per patient
 Inpatient servicesNumber of inpatient admissions0.98 (0.64–1.48)0.9071.01 (0.99–1.03)0.2081.11 (0.97–1.27)0.136
Number of days in hospital0.83 (0.40–1.73)0.6221.02 (0.99–1.04)0.2001.12 (0.87–1.43)0.392
 OutpatientNumber of outpatient visits1.01 (0.95–1.07)0.8261.00 (1.00–1.00)0.8411.07 (1.05–1.19)<0.0001
 MedicationPain medication, DDD1.01 (0.94–1.09)0.7771.00 (0.99–1.00)0.7631.01 (0.99–1.04)0.293
Other medication0.98 (0.93–1.03)0.4311.00 (0.99–1.00)0.3831.00 (0.98–1.02)0.767
Total0.98 (0.94–1.03)0.4771.00 (0.99–1.00)0.3441.01 (0.99–1.02)0.571
(B) Changes in health costs per patient
 Inpatient servicesDiseases of the musculoskeletal system and connective tissue0.61 (0.23–1.61)0.3211.03 (1.00–1.05)0.0661.19 (0.88–1.66)0.251
Other diseases0.99 (0.58–1.72)0.9841.03 (1.01–1.05)0.0021.00 (0.82–1.21)0.966
Total0.97 (0.60–1.58)0.9031.03 (1.01–1.04)0.0021.02 (0.87–1.21)0.784
 Outpatient servicesDiseases of the musculoskeletal system and connective tissue1.08 (0.98–1.19)0.1261.00 (0.99–1.00)0.9761.04 (1.00–1.08)0.072
Other diseases1.15 (0.89–1.48)0.2841.00 (0.99–1.01)0.3041.10 (1.01–1.19)0.028
Total1.08 (0.99–1.18)0.0931.00 (1.00–1.00)0.5211.04 (1.00–1.08)0.036
 Primary sectorGeneral practitioner1.07 (0.98–1.16)0.1531.00 (1.00–1.00)0.6821.04 (1.01–1.08)0.007
Other practicing specialist1.04 (0.80–1.36)0.7561.00 (0.99–1.01)0.6680.99 (0.89–1.09)0.810
Physiotherapist, chiropractor, foot specialist1.02 (0.91–1.15)0.7051.00 (1.00–1.00)0.2560.99 (0.95–1.04)0.754
Other1.06 (0.90–1.24)0.4841.00 (0.99–1.00)0.7190.98 (0.92–1.04)0.465
Total1.05 (0.98–1.13)0.1761.00 (1.00–1.00)0.4231.00 (0.98–1.03)0.769
 Medication§Pain medication0.99 (0.88–1.10)0.8231.00 (1.00–1.00)0.9571.03 (0.99–1.07)0.119
Other medication0.94 (0.85–1.04)0.2141.00 (0.99–1.00)0.3751.00 (0.97–1.04)0.835
Total0.96 (0.88–1.04)0.2871.00 (1.00–1.00)0.4041.01 (0.98–1.03)0.513
Total costs1.03 (0.94–1.14)0.5161.00 (1.00–1.01)0.0851.03 (0.99–1.07)0.146
  • Statistically significant results are marked with bold types.

  • †Adjusted for gender, age, dead in post period, duration of ETA before index date, stopped SB4 treatment within 180 days and comorbidities 12–24 months before index date.

  • ‡ETA duration as categories.

  • §Medication handled by prescription included (ETA, SB4 not included).